NDC 0378-9671-64 - Ipratropium Bromide and Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9671
- Requested NDC
- 0378-9671-64
- Package NDCs from labels
- 0378-9671-31, 0378-9671-93, 0378-9671-64, 0378-9671-30, 0378-9671-60
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2018-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2018-12-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9671-30 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 CARTON | SOLUTION | 1 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 POUCH | SOLUTION | 1 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 2 in 1 CARTON | SOLUTION | 2 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-93 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 CARTON | SOLUTION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9671-30 | ML - Milliliter | 0378-9671 | fecf8d7a-ca63-4086-a192-cfe09593da7f | 1 | 2016-03-04 |
| 0378-9671-31 | ML - Milliliter | 0378-9671 | 441e8202-3014-467f-839f-1cb56dd1ff5a | 1 | 2015-05-05 |
| 0378-9671-58 | ML - Milliliter | 0378-9671 | e0ed7cbb-725f-41b4-98a8-8e4fbac96aa5 | 1 | 2013-10-17 |
| 0378-9671-60 | ML - Milliliter | 0378-9671 | ac7fec3f-8285-492f-b246-26b74402bbb7 | 1 | 2016-04-04 |
| 0378-9671-91 | ML - Milliliter | 0378-9671 | 32a69a83-77f5-460b-ac59-cdb791096167 | 1 | 2014-04-03 |
| 0378-9671-93 | ML - Milliliter | 0378-9671 | f9a81245-211d-421f-9a2b-9b034708627c | 1 | 2013-07-02 |
| 0378-9671-98 | ML - Milliliter | 0378-9671 | d5fa01b8-04ef-4d82-bc9d-1bc4f51852f7 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albuterol Sulfate | ACTIVE INGREDIENT | 021SEF3731 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium Bromide | ACTIVE INGREDIENT | J697UZ2A9J | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Albuterol | ACTIVE MOIETY | QF8SVZ843E | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium | ACTIVE MOIETY | GR88G0I6UL | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | c90e80b2-882e-4c0c-bfac-d67eb1da724d | 2026-02-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Mylan Pharmaceuticals Inc. | 5329614f-ae0b-4854-bb6f-ea0b7dae87c0 | 2026-02-10 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulate HFA | ALBUTEROL SULFATE | REMEDYREPACK INC. | 77d34a3c-ccc6-420a-ad31-a1af55f7de76 | 2026-01-30 | Warnings, Adverse reactions | 021SEF3731 |
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Golden State Medical Supply, Inc. | 2ebc820b-a423-46ef-8eba-9fbc93daff44 | 2026-01-28 | Warnings, Adverse reactions | ANDA202496 1437702 J697UZ2A9J 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 1f0bf143-66d4-4a39-b2d1-a5c460ffdcf9 | 2026-01-22 | Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | REMEDYREPACK INC. | 2ed73618-be3a-4331-9509-6401258f791f | 2026-01-19 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 5de6a189-a8b7-4b33-b162-add6b6e4b275 | 2026-01-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | d6acb5a7-555a-463a-ae65-2911d6789b42 | 2026-01-14 | Warnings, Adverse reactions | 021SEF3731 |
| IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | Lupin Pharmaceuticals, Inc. | 13a45df5-a8e3-41d6-91f4-773255b5a04b | 2026-01-08 | Warnings, Adverse reactions | J697UZ2A9J |
| IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | Lupin Pharmaceuticals, Inc. | ee0ac556-8a23-4d5c-a5da-881c1fc6a339 | 2026-01-08 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol | ALBUTEROL SULFATE | Cipla USA Inc. | fd0389e0-3713-42e0-8ef2-3bb97676fded | 2026-01-04 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Chartwell Governmental & Specialty RX, LLC. | dd47559a-84f6-42a5-a00e-48754505418e | 2025-12-17 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Sandoz Inc | f8a2c4b7-a162-48ab-90b0-350e4da25c66 | 2025-12-16 | Warnings, Adverse reactions | 021SEF3731 |
| IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | Advagen Pharma Ltd | bb5f7711-595f-4f7c-9e89-66d029ccbccb | 2025-12-12 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Ritedose Pharmaceuticals, LLC | 22479633-624a-4251-ad3c-1dcba5d503fb | 2025-12-10 | Warnings, Adverse reactions | J697UZ2A9J |
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | e0dee492-8bf9-4360-be9b-9d6ee1ecb256 | 2025-12-10 | Warnings, Adverse reactions | ANDA202496 1437702 J697UZ2A9J 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Chartwell RX, LLC | 1e3d4faa-cf6e-460b-b1e0-fcc8094505fa | 2025-12-02 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Chartwell RX, LLC | b444478a-10ce-484f-9039-6383dfb8161e | 2025-12-02 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| Combivent Respimat | IPRATROPIUM BROMIDE AND ALBUTEROL | Boehringer Ingelheim Pharmaceuticals, Inc. | 9832312e-0310-4ab6-8501-afa976fc7eb2 | 2025-12-01 | Warnings, Adverse reactions | J697UZ2A9J 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Bryant Ranch Prepack | 378461f2-7271-44a3-9da3-b39970b65d3a | 2025-11-10 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.